Shares of Delcath Systems Inc. (NASDAQ:DCTH) rose 27.3% on Thursday . The stock traded as high as $4.49 and last traded at $3.87, with a volume of 259,251 shares. The stock had previously closed at $3.04.

The firm has a 50 day moving average of $3.95 and a 200 day moving average of $4.72. The firm’s market capitalization is $6.40 million.

Delcath Systems (NASDAQ:DCTH) last announced its earnings results on Wednesday, May 4th. The medical device company reported ($0.08) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.19) by $0.11. On average, equities analysts expect that Delcath Systems Inc. will post ($7.84) earnings per share for the current fiscal year.

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.